NRx Pharmaceuticals, Inc. (NRXP)
NASDAQ: NRXP · Real-Time Price · USD
3.010
-0.105 (-3.37%)
May 19, 2026, 2:51 PM EDT - Market open
NRx Pharmaceuticals Market Cap
NRx Pharmaceuticals has a market cap or net worth of $99.43 million as of May 19, 2026. Its market cap has increased by 186.55% in one year.
Market Cap
99.43M
Enterprise Value
97.12M
1-Year Change
186.55%
Ranking
Category
Stock Price
$3.01
Market Cap Chart
Since November 20, 2017, NRx Pharmaceuticals's market cap has increased from $65.80M to $99.43M, an increase of 51.12%. That is a compound annual growth rate of 4.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 112.90M | 48.36% |
| Dec 31, 2025 | 76.10M | 186.09% |
| Dec 31, 2024 | 26.60M | -31.09% |
| Dec 29, 2023 | 38.60M | -48.60% |
| Dec 30, 2022 | 75.10M | -73.28% |
| Dec 31, 2021 | 281.10M | 328.51% |
| Dec 31, 2020 | 65.60M | 2.02% |
| Dec 31, 2019 | 64.30M | -30.26% |
| Dec 31, 2018 | 92.20M | 44.97% |
| Dec 29, 2017 | 63.60M | -3.34% |
| Nov 20, 2017 | 65.80M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kalaris Therapeutics | 108.98M |
| enGene Therapeutics | 105.17M |
| PepGen | 101.68M |
| Verrica Pharmaceuticals | 100.84M |
| Inovio Pharmaceuticals | 99.96M |
| Vivani Medical | 98.31M |
| Cibus | 97.64M |
| Q32 Bio | 97.50M |